Rossby Financial’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.11M Buy
2,046
+165
+9% +$85.3K 0.16% 119
2026
Q2
$1.02M Sell
1,881
-3
-0.2% -$1.69K 0.19% 107
2026
Q1
$1.07M Buy
1,884
+69
+4% +$34.4K 0.22% 96
2025
Q4
$884K Buy
1,815
+85
+5% +$39.6K 0.27% 68
2025
Q3
$758K Sell
1,730
-73
-4% -$24.6K 0.25% 78
2025
Q2
$518K Buy
1,803
+499
+38% +$149K 0.19% 105
2025
Q1
$380K Buy
1,304
+586
+82% +$201K 0.16% 134
2024
Q4
$253K Buy
+718
New +$264K 0.16% 152

Other funds holding UTHR

Rossby Financial's UTHR Position: Q3 2026 in Review

Rossby Financial increased its United Therapeutics (UTHR) stake by 8.8% in Q3 2026, buying an estimated $85.3K and bringing the position to 2,046 shares worth $1.11M. The position accounts for 0.16% of the portfolio, ranked #119.

Rossby Financial first reported a position in UTHR in Q4 2024 and has held it in 8 quarters since. 477 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Rossby Financial held 2,046 shares of United Therapeutics worth $1.11M as of Q3 2026.
  • Rossby Financial bought 165 United Therapeutics shares in Q3 2026, an estimated $85.3K.
  • United Therapeutics made up 0.16% of Rossby Financial's portfolio in Q3 2026, its #119 holding.
  • Rossby Financial first reported a position in United Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • 477 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.